Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: PMDA GMP inspections Japan

How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India

Posted on January 29, 2025 By digi

How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India Understanding the Role of Schedule M Revised in Generic Drug Manufacturing Compliance Introduction to Schedule M Revised and Generic Drugs India is one of the largest producers of generic drugs, supplying affordable medicines to global markets. With the revision of Schedule…

Read More “How Schedule M Revised Ensures Compliance in the Manufacturing of Generic Drugs in India” »

GMP in India

How to Ensure GMP Compliance for Clinical Trials in Latin America and Africa

Posted on January 28, 2025 By digi

How to Ensure GMP Compliance for Clinical Trials in Latin America and Africa Essential Tips for GMP Compliance in Clinical Trials Across Latin America and Africa Introduction to GMP Compliance in Clinical Trials Conducting clinical trials in emerging markets such as Latin America and Africa offers significant opportunities due to diverse populations and cost advantages….

Read More “How to Ensure GMP Compliance for Clinical Trials in Latin America and Africa” »

GMP in Emerging Markets (GCC, Latin America, Africa)

Common Non-Conformities in Schedule M Revised Compliance and How to Address Them

Posted on January 28, 2025 By digi

Common Non-Conformities in Schedule M Revised Compliance and How to Address Them Tips to Avoid and Address Common Non-Conformities in Schedule M Revised Compliance Introduction to Schedule M Revised Compliance The revised Schedule M under the Drugs and Cosmetics Rules, 1945, aims to elevate India’s pharmaceutical manufacturing standards to align with global Good Manufacturing Practices…

Read More “Common Non-Conformities in Schedule M Revised Compliance and How to Address Them” »

GMP in India

Best Practices for GMP Documentation Under EMA and MHRA Regulations

Posted on January 28, 2025 By digi

Best Practices for GMP Documentation Under EMA and MHRA Regulations Effective Tips for GMP Documentation Compliance with EMA and MHRA Standards Introduction to GMP Documentation In the pharmaceutical industry, Good Manufacturing Practices (GMP) are critical for ensuring the safety, efficacy, and quality of medicinal products. Among the many aspects of GMP compliance, documentation plays a…

Read More “Best Practices for GMP Documentation Under EMA and MHRA Regulations” »

GMP in Europe (EMA, MHRA)

The Role of Supplier Quality Management in GMP Compliance in Emerging Markets

Posted on January 28, 2025 By digi

The Role of Supplier Quality Management in GMP Compliance in Emerging Markets How to Manage Supplier Quality for Effective GMP Compliance in Emerging Markets Introduction to Supplier Quality Management in GMP In Good Manufacturing Practices (GMP), supplier quality management is a crucial element for ensuring the safety, efficacy, and quality of pharmaceutical products. In emerging…

Read More “The Role of Supplier Quality Management in GMP Compliance in Emerging Markets” »

GMP in Emerging Markets (GCC, Latin America, Africa)

The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India

Posted on January 28, 2025 By digi

The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India Understanding the Role of Drug Regulatory Authorities in Enforcing Schedule M Revised Introduction to Schedule M Revised and Drug Regulation Schedule M Revised, under the Drugs and Cosmetics Rules, 1945, plays a crucial role in defining Good Manufacturing Practices (GMP) for the Indian…

Read More “The Relationship Between Schedule M Revised and Drug Regulatory Authorities in India” »

GMP in India

How GMP Affects Pharmaceutical Product Labeling in Europe

Posted on January 28, 2025 By digi

How GMP Affects Pharmaceutical Product Labeling in Europe A Comprehensive Guide to GMP’s Impact on Pharmaceutical Product Labeling in Europe Introduction to GMP and Pharmaceutical Labeling Good Manufacturing Practices (GMP) play a vital role in ensuring the safety, efficacy, and quality of pharmaceutical products. One often-overlooked but critical aspect of GMP compliance is its influence…

Read More “How GMP Affects Pharmaceutical Product Labeling in Europe” »

GMP in Europe (EMA, MHRA)

Best Practices for GMP Documentation in Pharmaceutical Manufacturing in Emerging Markets

Posted on January 27, 2025 By digi

Best Practices for GMP Documentation in Pharmaceutical Manufacturing in Emerging Markets Proven Tips for Effective GMP Documentation in Emerging Markets Introduction to GMP Documentation Good Manufacturing Practices (GMP) are vital for ensuring the quality, safety, and efficacy of pharmaceutical products. One of the most critical aspects of GMP compliance is proper documentation. In emerging markets…

Read More “Best Practices for GMP Documentation in Pharmaceutical Manufacturing in Emerging Markets” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets

Posted on January 27, 2025 By digi

How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets A Step-by-Step Guide to Leveraging Schedule M Revised for Global Pharmaceutical Exports Introduction to Schedule M Revised and Global Markets Schedule M Revised, under the Drugs and Cosmetics Rules, 1945, represents a significant step in aligning India’s pharmaceutical manufacturing standards with international Good…

Read More “How Schedule M Revised Supports Drug Manufacturing and Export to Global Markets” »

GMP in India

Common GMP Violations Under EMA and MHRA Guidelines and How to Avoid Them

Posted on January 27, 2025 By digi

Common GMP Violations Under EMA and MHRA Guidelines and How to Avoid Them Tips to Avoid Common GMP Violations Under EMA and MHRA Guidelines Introduction to GMP Compliance Adhering to Good Manufacturing Practices (GMP) is critical for ensuring the safety, quality, and efficacy of pharmaceutical products. Regulatory bodies like the European Medicines Agency (EMA) and…

Read More “Common GMP Violations Under EMA and MHRA Guidelines and How to Avoid Them” »

GMP in Europe (EMA, MHRA)

Posts pagination

Previous 1 … 17 18 19 … 26 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Ensure Tightness of Primary Packaging Before Dispatch in GMP

    Ensure Tightness of Primary Packaging… Read more

PMDA GMP inspections Japan

  • Health Canada GMP Inspection Process: What to Expect
  • The Role of GMP in Preventing Cross-Contamination in Asian Pharmaceutical Manufacturing
  • How FDA GMP Inspections Affect Pharmaceutical Manufacturing Efficiency
  • How to Maintain GMP Compliance for Pharma Products Manufactured in Asia
  • The Importance of Documentation for GMP Compliance in North America
  • How NMPA’s GMP Guidelines Influence the Production of APIs and Finished Drugs in China
  • The Role of Supplier Quality Management in FDA GMP Compliance
  • The Impact of KFDA GMP Guidelines on the South Korean Pharmaceutical Industry
  • The Relationship Between FDA GMP Regulations and Pharmaceutical Packaging
  • How to Address GMP Violations in Asian Pharmaceutical Manufacturing

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme